Protocol digest of randomized phase II study of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel combination therapy for locally advanced pancreatic cancer: Japan clinical oncology group study (JCOG1407)

A randomized phase II selection design trial comparing FOLFIRINOX and GnP for patients with locally advanced pancreatic cancer started in July 2016.

Source: Pancreatology - July 27, 2018 Category: Gastroenterology Authors: Junki Mizusawa, Akira Fukutomi, Hiroshi Katayama, Hiroshi Ishii, Tatsuya Ioka, Takuji Okusaka, Hideki Ueno, Makoto Ueno, Masafumi Ikeda, Nobumasa Mizuno, Masato Ozaka, Haruhiko Fukuda, Junji Furuse, Hepatobiliary and Pancreatic Oncology Group of the Japan Source Type: research